Neoadjuvant Toripalimab in Combination With Gemcitabine Therapy in Cisplatin Ineligible Local Advanved Bladder Cancer
Clinical trial NCT04553939 · COMPLETED
Trial details
- NCT number
- NCT04553939
- Sponsor
- Henan Cancer Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-04
- Primary completion
- 2023-04-12
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.